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Atherosclerosis is a disease of the vasculature 
that is characterized by chronic inflammation 
of the arterial wall (Hansson and Libby, 2006). 
The development of atherosclerosis is initiated 
by the activation of endothelial cells (ECs) 
leading to expression of adhesion molecules for 
inflammatory cells (Berk, 2008). In addition, 
these activated ECs facilitate the passage of   
lipid components in the plasma, such as low-
density lipoproteins (LDLs; Hansson, 2005).   
A critical element in the progression of athero-
sclerosis is the development of an oxidizing   
environment caused by the activation of mac-
rophages that become loaded with oxidized 
LDL  and  other  lipids.  These  macrophages 
produce reactive oxygen species (ROS) and 
secrete cytokines and growth factors that con-
tribute to the progression of atherosclerotic 
plaques and promote vulnerable lesions (Weber 
et al., 2008).
Cyclophilin A (CyPA) is a ubiquitously 
distributed protein belonging to the immuno-
philin family recognized as the intracellular re-
ceptor for the potent immunosuppressive drug 
cyclosporine A (CsA; Handschumacher et al., 
1984). CyPA possesses peptidyl-prolyl isom-
erase activity and plays an important role in   
protein  folding  and  trafficking  (e.g.,  nuclear 
translocation of ERK1/2 [Pan et al., 2008] and 
AIF  [apoptosis-inducing  factor;  Zhu  et  al., 
2007]). Interestingly, it has been shown that 
CyPA is a part of a cytosolic trafficking com-
plex consisting of caveolin, heat-shock pro-
tein 56, cyclophilin 40, CyPA, and cholesterol 
(Uittenbogaard et al., 1998). Although CyPA 
was initially believed to function primarily as 
an intracellular protein, recent studies have   
revealed  that  it  can  be  secreted  by  cells  in   
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Cyclophilin A (CyPA; encoded by Ppia) is a ubiquitously expressed protein secreted in  
response to inflammatory stimuli. CyPA stimulates vascular smooth muscle cell migration 
and proliferation, endothelial cell adhesion molecule expression, and inflammatory cell 
chemotaxis. Given these activities, we hypothesized that CyPA would promote athero­
sclerosis. Apolipoprotein E–deficient (Apoe/) mice fed a high­cholesterol diet for 16 wk  
developed more severe atherosclerosis compared with Apoe/Ppia/ mice. Moreover,  
CyPA deficiency was associated with decreased low­density lipoprotein uptake, VCAM­1  
(vascular cell adhesion molecule 1) expression, apoptosis, and increased eNOS (endothelial 
nitric oxide synthase) expression. To understand the vascular role of CyPA in atherosclerosis 
development, bone marrow (BM) cell transplantation was performed. Atherosclerosis was 
greater in Apoe/ mice compared with Apoe/Ppia/ mice after reconstitution with 
CyPA+/+ BM cells, indicating that vascular­derived CyPA plays a crucial role in the progres­
sion of atherosclerosis. These data define a role for CyPA in atherosclerosis and suggest 
CyPA as a target for cardiovascular therapies.
© 2011 Nigro et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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RESULTS
Atherosclerosis development is dependent on CyPA
To study the functional role of CyPA in atherogenesis, we 
used the Apoe/ mouse, a well-known model of atheroscle-
rosis (Nakashima et al., 1994). We generated Apoe/Ppia/ 
(double knockout) mice, and fed them a high-cholesterol diet 
for  16  wk.  To  visualize  lipid-rich  atherosclerotic  plaques,   
aortas were stained with Oil red O. As shown in Fig. 1 A, 
Apoe/Ppia/ mice compared with Apoe/ mice exhibited 
significantly less atherosclerosis: aortic coverage of 7.5 ± 2% in 
Apoe/Ppia/ versus 19.3 ± 8.2% in Apoe/ (Fig. 1 B).
In another cohort of mice, we quantified plaque area in 
hematoxylin- and eosin (H&E)-stained cross sections of the 
aortic arch and thoracic aorta. Lesion area was significantly 
decreased in both the aortic arch (Fig. 1, C and D) and tho-
racic aorta (Fig. 1, C and E) of Apoe/Ppia/ mice com-
pared with Apoe/ mice. As expected, the elastic lamina was 
frequently degraded with large regions exhibiting disruption 
in Apoe/ mice compared with Apoe/Ppia/ mice (Fig. S1). 
These results demonstrate a remarkable reduction in athero-
sclerosis in CyPA-deficient mice and strongly support our 
hypothesis that CyPA contributes to atherosclerosis.
The absence of CyPA decreases the lesion area  
and the migration of macrophages in the aortic sinus
The aortic sinus is particularly prone to intimal lesion develop-
ment, and the cusps of the valves provide a useful positional cue 
in comparative experiments of sectioned tissues   
(Tangirala et al., 1995). As shown in Fig. 2   
(A and B), Apoe/Ppia/ mice compared with 
Apoe/ mice exhibited significantly less athero-
sclerosis measured by plaque area (H&E staining). 
There was also significantly less lipid deposition 
and cholesterol clefts in Apoe/Ppia/ mice   
(Fig. 2 A, Masson and Trichrome and Oil red 
O).  Both  H&E  and  Masson  and  Trichrome 
showed a significant reduction in intima forma-
tion in Apoe/Ppia/ mice (Fig. 2 A).
A crucial step in atherogenesis is the infil-
tration of monocytes into the subendothelial 
space of large arteries where they differentiate 
response to inflammatory stimuli, especially ROS (Jin et al., 
2000; Suzuki et al., 2006; Satoh et al., 2009). Extracellular 
CyPA  is  a  potent  leukocyte  chemoattractant  for  human 
monocytes, neutrophils, eosinophils, and T cells (Sherry et al., 
1992; Xu et al., 1992; Allain et al., 2002; Yurchenko et al., 
2002; Arora et al., 2005; Damsker et al., 2007; Pan et al., 2008), 
and  it  stimulates  inflammatory  responses  when  injected   
in vivo (Sherry et al., 1992). Most importantly, plasma CyPA 
is significantly increased in patients with inflammatory dis-
eases such as rheumatoid arthritis (Kim et al., 2005) and sepsis 
(Tegeder et al., 1997). We have shown that ROS promote 
secretion  of  CyPA  from  vascular  smooth  muscle  cells 
(VSMCs; Jin et al., 2000; Liao et al., 2000) and that extracel-
lular CyPA stimulates EC adhesion molecule expression in   
vitro (Jin et al., 2004; Suzuki et al., 2006). Furthermore, we 
found that CyPA mediates vascular remodeling by promot-
ing inflammation and VSMC proliferation (Satoh et al.,   
2008), and it is indispensable for the development of an-
giotensin II–induced aortic aneurysms (Satoh et al., 2009; 
Weintraub, 2009).
Given these functions of CyPA, we hypothesized that 
CyPA would contribute to the development of atherosclero-
sis. In this study, we report that CyPA is atherogenic by   
enhancing LDL uptake, adhesion molecule expression, and 
inflammatory cell migration. Our data suggest that CyPA   
and its signaling pathways are novel targets for atheroscle-
rosis therapy.
Figure 1.  CyPA deficiency limits atherosclerosis 
formation. (A) Representative photographs showing  
Oil red O staining of aortas from Apoe/ and  
Apoe/Ppia/ mice fed a high-cholesterol diet for  
16 wk. (B) Lesion area was significantly decreased in  
Apoe/Ppia/ mice (n = 15) compared with Apoe/ 
mice (n = 21). (C) Longitudinal cross sections from the 
aortic arch and thoracic aorta stained with H&E. Bars: 
(left) 25 µm; (right) 200 µm. (D and E) Quantification of 
plaque area showed that Apoe/Ppia/ mice (n = 7) 
exhibited decreased atherosclerosis compared with 
Apoe/ mice (n = 9) in both the aortic arch (D) and 
thoracic aorta (E). (B, D, and E) Results are mean ± SD;  
*, P < 0.01 compared with Apoe/ mice. Results in A–E 
show pooled data from two experiments.JEM VOL. 208, January 17, 2011 
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radioactivity as measured by a gamma counter. As shown in 
Fig.  S3,  LDL  uptake  was  significantly  reduced  in  aortas 
from Apoe/Ppia/compared with Apoe/ mice. To gain 
insight into how CyPA regulates lipid uptake, we examined 
expression  of  several  scavenger  receptors  in  aortas  after   
12 wk of high-cholesterol diet. The expression of lectin-
like oxidized LDL receptor (LOX-1) and CD36 were sig-
nificantly decreased in Apoe/Ppia/ mice compared with 
Apoe/ mice, whereas SR-BI was decreased by an equiva-
lent 40% (Fig. 3, C and D). The expression of SR-A did not 
differ  significantly  between  Apoe/  and  Apoe/Ppia/ 
mice (Fig. 3, C and D). Collectively, the data demonstrate 
that CyPA influences LDL uptake by regulating the expres-
sion of scavenger receptors on the vessel wall.
CyPA deficiency induces the development of a more 
proatherogenic lipoprotein profile in Apoe/ mice
Next, we performed phenotypic characterization of Apoe/ 
and  Apoe/Ppia/  mice  fed  a  high-cholesterol  diet  for   
16 wk. Body weights were similar in all the groups of mice 
before and after a high-cholesterol diet (Fig. S4 A). There 
were no significant differences in plasma cholesterol and tri-
glyceride levels (Fig. S4, B and C). We next examined lipo-
protein profiles by gel filtration chromatography (Fig. S4 D). 
into macrophages and become functionally active (Galkina and 
Ley, 2009). As shown in Fig. 2 (A and D), the Apoe/Ppia/ 
mice fed high-cholesterol diet for 16 wk showed significantly 
fewer Mac3-positive macrophages compared with the Apoe/ 
mice. All these data suggest that CyPA is a key protein in-
volved in the atherosclerosis progression and migration of in-
flammatory cells in the lesion area.
CyPA regulates LDL infiltration and the expression  
of scavenger receptors
Because it is well established that the transport of LDL cho-
lesterol into the artery wall is the initiating event that trig-
gers atherosclerosis (Glass and Witztum, 2001), we examined 
the role of CyPA in this process. To measure LDL uptake 
into vessels of Apoe/ and Apoe/Ppia/ mice, we per-
formed  ex  vivo  incubation  with  fluorescent  DiI-labeled 
LDLs and en face imaging of the aorta from the EC surface 
to  a  depth  of  50  µm  into  the  intima.  CyPA  deficiency 
caused a 43% decrease in DiI-LDL uptake in the lesser cur-
vature of the aortic arch (atherosclerosis-prone area; Fig. 3, 
A and B; and Fig. S2). To strengthen this important finding, 
we  confirmed  these  data  with  an  independent  method. 
Apoe/ and Apoe/Ppia/ aortas were incubated with 
[125I]LDL for a subsequent determination of incorporated 
Figure 2.  CyPA deficiency reduces lesion size and inflammatory cell accumulation in the aortic sinus. (A) Representative histological analysis of 
the aortic sinus stained with H&E, Masson and Trichrome, Oil red O, Mac3 (a macrophage marker), and -smooth muscle cell actin (-SMA). Insets are 
higher magnification images of the areas in the dashed boxes. Bars, 100 µm. (B–D) Quantification of the plaque area (B), lipid accumulation (C), and  
macrophage accumulation (D) shows a significant reduction in Apoe/Ppia/ mice (n = 7) compared with Apoe/ (n = 9) mice. Results are mean ± SD; 
*, P < 0.01 compared with Apoe/ mice. Results in A–D show pooled data from two experiments.56 Cyclophilin A contributes to atherosclerosis | Nigro et al.
To determine the role of BM-derived CyPA in atherosclero-
sis, BM transplantation experiments were performed.
BM cells from Apoe/ and Apoe/Ppia/ mice were 
transplanted into 6-wk-old lethally irradiated Apoe/ mice. 
After 4 wk of reconstitution, mice were fed with a high- 
cholesterol diet for 12 wk. Surprisingly, there were no differ-
ences in atherosclerosis measured by lesion area in the entire   
aorta (Fig. 4, A and B; Oil red O) or aortic root (Fig. 4,   
C and D; H&E). These data demonstrate that atherosclerosis 
in Apoe/Ppia/ mice was not altered by specific CyPA de-
ficiency in BM-derived cells. Note that the atherosclerosis   
lesion area was reduced by 50% in Apoe/ mice after irra-
diation (compare Fig. 4 B with Fig. 1 B).
We next assessed the development of high-cholesterol–
induced  atherosclerosis  in  Apoe/Ppia/  chimeric  mice 
that were transplanted with Apoe/ BM or Apoe/Ppia/ 
BM. There was no significant difference in atherosclerosis   
lesions between the chimeric mice with Apoe/ BM versus 
Apoe/Ppia/ BM (unpublished data).
Although there were no differences observed in cholesterol 
and triglyceride levels, Apoe/Ppia/ mice demonstrated 
increases in the VLDL (very low-density lipoprotein)- and 
IDL (intermediate-density lipoprotein)/LDL-sized lipopro-
teins compared with Apoe/ mice. No differences were ob-
served in the HDL (high-density lipoprotein) fraction or in 
the levels of plasma apoB-100 and apoB-48 (Fig. S4 E).   
Collectively, these results indicate that loss of CyPA, in the 
context of the Apoe/ genetic background, leads to the ap-
pearance of a more proatherogenic lipoprotein profile.
BM­derived CyPA does not play a significant role  
in atherosclerosis formation
CyPA has important roles in the immune system and is a well-
described regulator of T lymphocyte functions (Colgan et al., 
2004). Extracellular CyPA is a potent chemoattractant for in-
flammatory cells (Xu et al., 1992; Allain et al., 2002; Yurchenko 
et al., 2002). CyPA has also been reported to stimulate migra-
tion of BM-derived cells in vitro (Khromykh et al., 2007). 
Figure 3.  CyPA regulates LDL entry into the aortic wall and the expression of the scavenger receptors. (A) En face fluorescence images of  
aortic arches from 6-wk-old Apoe/ and Apoe/Ppia/ mice (n = 3 each group) after incubation with DiI–labeled LDL (red) and SYTOX green nucleic 
acid stain (green). (B) Quantification of DiI-LDL fluorescence intensity from the en face images. The data are quantified as fluorescence-positive area.  
(C) Western blot analyses of aortic extracts from Apoe/ and Apoe/Ppia/ mice fed a high-cholesterol diet for 12 wk. Results for three representative 
mice are shown for each genotype. (D) Densitometric analyses of the blots in C show significant decreases in LOX-1, CD36, and SR-BI scavenger receptors 
in Apoe/Ppia/ mice versus Apoe/ mice. (B and D) Results are mean ± SD; *, P < 0.01 compared with Apoe/ mice. Results in A–D show pooled 
data from two experiments.JEM VOL. 208, January 17, 2011 
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much greater in the Apoe/ recipient mice (Fig. 4 E, left) 
compared with Apoe/Ppia/ recipient mice (Fig. 4 E, 
right) after high-cholesterol diet. High-magnification im-
ages (Fig. 4 G, top) showed the presence of enlarged foam 
cells in the Apoe/ mice with GFP+ BM (arrows), which 
is consistent with the concept that BM-derived cells dif-
ferentiate into foam cells upon exposure to hyperlipidemia.   
Direct  demonstration  that  the  BM-derived  GFP+  cells 
were localized beneath the ECs (and not just adherent to 
the luminal surface) was obtained by examination of cross- 
sectional images of z-series stacks (Fig. 4 G, bottom). These 
results suggested that CyPA present in BM-derived cells   
is less important for recruitment to the sites of atheroscle-
rosis lesions than CyPA present in vessels and other non-
BM cells.
To investigate the chemoattractive function of CyPA in 
vivo, we studied the trafficking of BM-derived cells into 
atherosclerotic lesions. To analyze BM cells that migrated 
into lesions, we used donor BM cells harvested from mice 
constitutively expressing the GFP protein (GFP+ BM which 
are Ppia+/+) and performed BM transplantation in lethally 
irradiated Apoe/ and Apoe/Ppia/ mice. There was   
no significant difference in the reconstitution ratio (per-
centage of GFP+ cells in the peripheral blood) in GFP+ BM-
transplanted Apoe/Ppia/ mice compared with GFP+ 
BM-transplanted Apoe/ mice. However, there was still a 
significant difference in the atherosclerosis lesion area in the 
Apoe/ GFP+ BM mice compared with Apoe/Ppia/ 
GFP+ BM mice (9.6 ± 1.3% vs. 2.3 ± 0.3%), and migra-
tion of GFP+ BM cells into the lesser curvature region was 
Figure 4.  BM­derived CyPA is not crucial in atherosclerosis. (A) Representative Oil red O staining of aortas from Apoe/ mice transplanted  
with Apoe/ BM (n = 7) or Apoe/Ppia/ BM (n = 8) and fed a high-cholesterol diet for 12 wk. (B) Quantification of the lesion area shows that  
BM transplant of Apoe/Ppia/ cells does not decrease lesion development in Apoe/ mice. (C and D) Representative histological analysis of aortic 
sinus stained with H&E (C) and quantification of the aortic root lesion area (D). (B and D) Results are mean ± SD; P > 0.01. (E) Ppia+/+ BM cells (GFP+)  
were transplanted into irradiated Apoe/ (n = 4) or Apoe/Ppia/ (n = 4) mice as described in Materials and methods. Representative PECAM-1  
en face staining (Alexa Fluor 546; red) and migration of the GFP+ cells in aortic arch from Apoe/ and Apoe/Ppia/ mice with Ppia+/+ BM under  
high-cholesterol diet for 12 wk. (F) Number of migrating GFP+ cells was dramatically higher in the aortic wall of Apoe/ (n = 4) compared with  
Apoe/Ppia/ mice (n = 4). Results are mean ± SD; *, P < 0.01 compared with Apoe/ mice. (G) En face confocal microscopy of aortic arch from 
Apoe/ mice transplanted with GFP+ cells. Top panel shows foam cells, which were identified by large size and diffuse GFP pattern (arrows). Bottom 
panel shows the reconstruction in z axis of the images shown in the top panel. GFP+ cells are clearly present in the subendothelial space defined by the 
PECAM-1 positive fluorescence above them. Results in A–G show pooled data from two experiments. Bars: (C) 100 µm; (E and G) 10 µm.58 Cyclophilin A contributes to atherosclerosis | Nigro et al.
eNOS  function  is  critical  for  vascular  homeostasis  via 
generation of NO, and its loss is proatherogenic (Knowles   
et al., 2000; Chen et al., 2001; Kuhlencordt et al., 2001;   
Kawashima and Yokoyama, 2004). Furthermore, the pro-
gression of atherosclerosis is associated with decreases in both 
eNOS expression (Oemar et al., 1998; Handa et al., 2008) 
and NO production (Li and Förstermann, 2009). Therefore, 
we compared eNOS expression in aortas from Apoe/ and 
Apoe/Ppia/ mice by en face staining. As shown in Fig. 6 A, 
eNOS  protein  expression  was  significantly  higher  in  the 
Apoe/Ppia/ mice compared with Apoe/ mice. In addi-
tion, the location of eNOS differed, being predominantly 
perinuclear in the Apoe/ mice and diffuse (especially mem-
brane associated) in the Apoe/Ppia/ mice. To define the 
mechanisms responsible for decreased eNOS expression, we 
studied the effect of altering CyPA levels in cultured human 
umbilical vein ECs (HUVECs). To increase eNOS expression 
and stimulate cellular responses that are atheroprotective, 
cells were placed in a cone and plate viscometer, and steady 
laminar s-flow at physiological shear stress (12 dyn/cm2; termed 
s-flow here) was applied. As shown in Fig. 6 (B and C), s-flow–
mediated induction of eNOS was significantly increased by 
CyPA regulates endothelial nitric oxide (NO) synthase 
(eNOS) expression
The aforementioned results suggest that the athero protec-
tion observed in the Apoe/Ppia/ was caused by decreased 
inflammation mediated by the absence of CyPA. The vascu-
lar endothelium by virtue of its strategic location between the 
plasma and the underlying tissue is endowed with a large   
array of functions that are vital for the initiation of atheroscle-
rosis. Therefore, we performed an extensive examination of 
the endothelium of aortic arch and thoracic aorta by using 
PECAM-1 en face staining to visualize ECs. Apoe/Ppia/ 
mice showed a decreased EC disorganization in both the   
aortic segments when compared with Apoe/ mice (Fig. S5,   
A and B).
To evaluate further the mechanisms by which CyPA pro-
motes inflammation, we measured VCAM-1 (vascular cell 
adhesion molecule 1) expression, which is highly expressed 
in activated ECs and promotes atherosclerosis (Cybulsky and 
Gimbrone, 1991; Nakashima et al., 1998; Cybulsky et al., 2001). 
En face staining (Fig. 5, A and B) of aortic tissues showed   
that VCAM-1 expression was significantly reduced in mice 
lacking CyPA.
Figure 5.  VCAM­1 expression is significantly down­regulated in Apoe/Ppia/ mice compared with Apoe/ mice. (A) Representative  
en face staining for VCAM-1 expression (Alexa Fluor 546; red) in the aortic arch. EC morphology was changed in the atherosclerosis regions where ECs  
are stretched and may have lost PECAM-1 staining (Alexa Fluor 488; green) at some cell junctions. Bars, 10 µm. (B) Densitometric analysis of the en face 
staining also shows a significant reduction in VCAM-1 expression in Apoe/Ppia/ mice compared with Apoe/ mice (n = 4 each group). Results are 
mean ± SD; *, P < 0.01 compared with Apoe/ mice. Results in A and B show pooled data from two experiments.JEM VOL. 208, January 17, 2011 
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levels in HUVECs (Fig. 7 F). These 
findings illustrate a novel mechanism 
by which CyPA promotes atheroscle-
rosis,  through  suppression  of  KLF2 
expression and consequent repression 
of eNOS transcription.
CyPA affects eNOS expression  
by a ROS­dependent mechanism
ROS are key mediators of signaling pathways that underlie 
vascular inflammation in atherogenesis. We have previously 
shown that CyPA is a key determinant for ROS generation, 
contributing to the onset of vascular inflammation during 
aortic aneurism formation (Satoh et al., 2009). Therefore, we 
evaluated whether ROS are downstream mediators of CyPA   
in the pathophysiologic context of inflammation we ob-
served. We first overexpressed CyPA in ECs, and then we 
evaluated  the  basal  level  of  ROS  by  dichlorofluorescein 
(DCF;  Fig.  8  A)  and  dihydroethidium  (DHE;  Fig.  8  B) 
staining. ROS production was significantly higher in ECs 
overexpressing CyPA compared with cells transfected with 
the vector control (4.2- and 1.6-fold increase in DCF and 
DHE fluorescence, respectively). These data suggest that CyPA 
plays a critical role in ROS generation in ECs similar to our 
findings in VSMCs (Satoh et al., 2009).
CyPA small interfering RNA (siRNA). Also, CyPA knock-
down in HUVECs increased eNOS promoter activity and 
eNOS messenger RNA (mRNA) levels (Fig. 6 D). Parmar   
et al. (2006) have shown that the s-flow induction of the KLF2 
(Kruppel-like factor 2) transcription factor stimulates eNOS 
mRNA expression through the ERK5–MEF2–KLF2 path-
way. Therefore, we examined whether CyPA could regulate 
KLF2 expression. As expected, s-flow increased KLF2 pro-
moter activity and KLF2 mRNA levels (Fig. 6 E). These effects 
were significantly increased by CyPA knockdown. To fur-
ther substantiate the role of CyPA in the regulation of eNOS 
expression, we transfected HUVECs with WT CyPA (CyPA-
WT). Overexpression of CyPA was accompanied by down-
regulation of eNOS at protein (Fig. 7, A and B) and mRNA 
levels (Fig. 7 C). Consistent with the expression data, over-
expression of CyPA decreased eNOS promoter activity   
in HUVECs (Fig. 7 D). Finally, overexpression of CyPA   
decreased KLF2 promoter activity (Fig. 7 E) and mRNA 
Figure 6.  CyPA deficiency and s­flow are 
associated with increased eNOS expres­
sion. (A) Aortas from 12-wk Apoe/ and 
Apoe/Ppia/ mice were harvested for 
qualitative analysis of eNOS expression (Alexa 
Fluor 546; red) by en face dual staining im-
munofluorescence. PECAM-1 staining (Alexa 
Fluor 488; green) was used to identify the EC 
layer. Note that these images were obtained 
from the thoracic aorta, a region of s-flow. 
eNOS protein expression was higher in  
Apoe/Ppia/ mice compared with Apoe/ 
mice aortas (relative fluorescence of 147 ± 
18.48 in Apoe/Ppia/ vs. 100 ± 13.61 in 
Apoe/; n = 3 each group). Bars, 10 µm.  
(B and C) HUVECs were transfected with  
CyPA siRNA or scrambled siRNA for 48 h as 
described in Materials and methods and then 
exposed to s-flow for 24 h. Western blot analysis   
shows significantly greater eNOS expression 
after depletion of CyPA. (D and E) HUVECs 
were treated for 48 h with CyPA siRNA or 
scrambled siRNA and then transfected with 
eNOS (D) or KLF2 (E) promoter. Cells were  
then exposed to s-flow or maintained in  
static condition. To evaluate the promoter 
function, luciferase activity was measured 
after 24 h. To measure eNOS and KLF2 mRNA 
levels, a quantitative PCR analysis was per-
formed. (C–E) Results are mean ± SD of three 
independent experiments performed in tripli-
cate. *, P < 0.01 versus scrambled siRNA.60 Cyclophilin A contributes to atherosclerosis | Nigro et al.
effect was significantly decreased to 6.65 ± 0.07% by using 
CyPA siRNA (Fig. 9 A). To better discriminate between 
apoptosis and necrosis (sub-G1 cell count might also include 
necrotic cells), we performed the double staining with an-
nexin V (FITC) and propidium iodide (PI), followed by flow 
cytometry  analysis.  Representative  cytograms  in  Fig.  9  B 
show that cells transfected with scrambled siRNA and treated 
with TNF plus CHX increased both the percentage of cells 
gated in the top right quadrant (annexin+/PI+; late apoptotic/
necrotic cells) and in the bottom right quadrant (annexin+/
PI; early apoptosis). Transfection of CyPA siRNA sig-
nificantly attenuated this effect. Moreover, ECs lacking 
CyPA showed less cleaved caspase-3 expression by Western 
blot analysis (Fig. 9 C). Because EC apoptosis has been sug-
gested as an initial step in atherogenesis, we studied EC apop-
tosis in the early stages of the lesion development in mice fed 
with a high-cholesterol diet for only 1 mo. As shown in Fig. 9 
(D and E), there was a marked decrease in apoptotic ECs 
(detected  by  terminal  deoxynucleotidyl  transferase  dUTP 
nick end labeling [TUNEL] staining) in aortic lesions from 
Apoe/Ppia/ mice compared with littermate control mice. 
These data underline the crucial role of CyPA during the 
apoptotic process that is an important early event for the de-
velopment of atherosclerosis.
DISCUSSION
The major finding of this study is that CyPA deficiency in 
vivo decreases atherosclerotic lesion burden in a mouse model 
of atherosclerosis. We characterized five important patholog-
ical mechanisms by which vascular CyPA promotes athero-
sclerosis. First, CyPA increases LDL uptake in the vessel wall 
by regulating the expression of scavenger receptors. Second, 
CyPA increases EC activation and inflammation by increas-
ing VCAM-1 expression. Third, CyPA decreases eNOS ex-
pression  through  KLF2  transcriptional  repression.  Fourth, 
CyPA is a key determinant for TNF-induced EC apoptosis. 
Finally, CyPA stimulates recruitment of inflammatory cells 
derived from the BM to the aortic wall. All of these mecha-
nisms, while promoting an environment of oxidative stress, 
are likely to contribute to the increased atherosclerosis ob-
served in the Apoe/Ppia+/+ mice.
The decrease in Oil red O staining is consistent with the 
decrease of multiple lipid uptake receptors in vessels of 
Apoe/Ppia/ mice. It is likely that CyPA regulates scaven-
ger  receptor  expression  by  multiple  mechanisms.  Because 
CyPA is a chaperone protein, it may be necessary for appro-
priate folding and/or transport of LOX-1 and CD36 to the 
cell membrane. CD36 is mainly expressed in caveolae, and 
CyPA is essential for caveolae formation via transport of cho-
lesterol and caveolin-1 (Uittenbogaard et al., 1998; Everson 
and Smart, 2001). In addition, both LOX-1 and CD36 are 
highly regulated by ROS and cytokines, which are markedly 
reduced in the Apoe/Ppia/ mice.
The  decrease  in  VCAM-1  expression  and  increase  in 
eNOS expression observed in Apoe/Ppia/ mice likely 
contributes to less inflammation. The decrease in VCAM-1 
To demonstrate that ROS are key determinants in CyPA-
mediated  inflammation,  we  evaluated  whether  CyPA  de-
creases eNOS expression by a ROS-dependent mechanism. 
Both the antioxidants N-acetyl-cysteine and Tiron, by rebal-
ancing excessive ROS production induced by CyPA overex-
pression, reversed the CyPA-mediated inhibition of eNOS 
(Fig. 8 C) and KLF2 promoter activity (Fig. 8 D). These data 
demonstrated  that  CyPA  induces  inflammation  through 
ROS-dependent mechanisms. Based on these results, we be-
lieve that CyPA, acting as a proinflammatory cytokine, syn-
ergistically augments ROS production, contributing to vascular 
inflammation and atherogenesis.
Deletion of CyPA decreases EC apoptosis
To ascertain whether intracellular CyPA may participate in 
the EC apoptosis, we knocked down CyPA in bovine aortic 
ECs (BAECs) by siRNA and measured hypodiploidia (sub-
G1 cell count) after treatment with TNF plus cycloheximide 
(CHX) as apoptogens. TNF promoted 11.95 ± 0.07% cell 
death in cells transfected with scrambled siRNA, and this   
Figure 7.  CyPA overexpression decreases eNOS and KLF2 expres­
sion. (A) HUVECs were transfected with CyPA-WT for 24 h and then ex-
posed to static and s-flow condition for a further 24 h. (A–F) Western blot 
data and quantitative PCR analysis revealed that CyPA overexpression 
inhibited s-flow–induced eNOS protein (A and B), eNOS mRNA (C), and 
also KLF2 mRNA (F) levels. HUVECs were cotransfected with CyPA-WT and 
with either eNOS (D) or KLF2 (E) promoter. The cells were exposed to static 
or s-flow condition, and the luciferase activity was measured after 24 h. 
Overexpression of CyPA decreases eNOS and KLF2 promoter activity. Data 
are the mean values ± SD of three independent experiments performed in 
triplicate. *, P < 0.01 versus control pcDNA3.1.JEM VOL. 208, January 17, 2011 
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regulated KLF2 function remains to be elucidated, although 
a nuclear function for CyPA has been suggested for CXCR4 
signaling (Pan et al., 2008).
An essential role for CyPA in apoptosis has become in-
creasingly apparent. We showed that extracellular CyPA   
promoted EC apoptosis in association with increased JNK 
(c-Jun N-terminal kinase) and p38 activities (Jin et al., 2004). 
In this study, we found that knockdown of CyPA in ECs   
reduced TNF-induced apoptosis in vitro, and CyPA defi-
ciency was associated with a marked decrease in EC apoptosis 
in early stages of atherosclerosis. A likely mechanism for 
CyPA-mediated apoptosis is binding and nuclear transloca-
tion of AIF (Zhu et al., 2007). In addition, the increase in the 
vascular oxidative stress requires CyPA (Satoh et al., 2009) 
and thereby sensitizes ECs to apoptosis.
CyPA may play an important role in several stages of ath-
erosclerosis. During fatty streak formation, it may play a role 
in lipid uptake via its effect on scavenger receptors. In all 
may be causally related to increased eNOS expression be-
cause it was previously shown that eNOS can down-regulate 
VCAM-1 expression (Kawashima et al., 2001). Consequently, 
there will be reduced monocyte adhesion to the endothe-
lium,  transmigration  into  the  subendothelial  space,  and   
inflammation. It may be relevant to note that VCAM-1 ex-
pression appears to precede lesion formation (Nakashima et al., 
1998; Cybulsky et al., 2001), suggesting an important role   
for CyPA in the initiation of atherosclerotic lesions. More-
over, we found that CyPA decreased eNOS expression by 
repressing KLF2 at the transcriptional level. This finding is of 
significant interest because KLF2 is a central regulator of EC 
biology (Atkins and Jain, 2007), and it has recently been 
shown that hemizygous deficiency of KLF2 increased high-
cholesterol  diet–induced  atherosclerosis  in  Apoe/  mice 
(Atkins et al., 2008). KLF2 also protects ECs from oxidative 
stress–mediated injury and subsequent apoptosis (Parmar   
et al., 2006). The mechanism by which CyPA negatively 
Figure 8.  CyPA increases ROS levels in ECs. (A and B) HUVECs were transfected with CyPA-WT and vector control. After 48 h of incubation, ROS 
levels were measured by determining DCF (A) and DHE (B) fluorescence. CyPA overexpression significantly increased ROS content in cells. Data are the 
representation of three independent experiments performed in triplicate. *, P < 0.01 vs. control pcDNA3.1. (C and D) HUVECs were transfected with  
CyPA-WT and vector control. After 24 h, cells were treated with 1 mM N-acetyl-cysteine and 10 mM Tiron. 16 h later, eNOS (C) and KLF2 (D) promoter 
activity were measured by luciferase assay. Data are the mean values ± SD of three independent experiments performed in triplicate. *, P < 0.01 versus 
control pcDNA3.1.62 Cyclophilin A contributes to atherosclerosis | Nigro et al.
We would like to point out that studies in animals and 
humans, although contradictory and not conclusive, have re-
ported that CsA, the immunosuppressive drug that inhibits 
CyPA, increases hyperlipidemia and risk of atherosclerosis 
(Fernández-Miranda et al., 1998; Ojo, 2006; Kockx et al., 
2010). We also reported that decreasing cholesterol content 
in  caveolae  by  CsA  is  a  potentially  important  pathogenic 
mechanism  for  CsA-induced  endothelial  dysfunction  and 
atherosclerosis (Lungu et al., 2004). These findings appear to 
contradict our data. However, the diversity of the pathways 
affected by CsA does not allow for simple conclusions to be 
drawn. CsA also affects many cellular pathways not associated 
stages, it may play a role in inflammation by promoting 
monocyte adhesion and recruitment as well as contributing 
to an oxidative environment. The data from Seizer et al. 
(2010) showing that CyPA is secreted from foam cells suggest 
an important role in later stages of atherosclerosis. Finally, we 
have recently shown an essential role for CyPA for matrix 
metalloproteinase activation (Satoh et al., 2009), suggesting 
that CyPA may also play an important role in plaque rup-
ture. Altogether, our data suggest that the agents that inhibit 
CyPA expression or agents that block CyPA receptors might 
be candidates that may regulate atherosclerotic plaque and   
its rupture.
Figure 9.  CyPA deficiency reduces EC apoptosis in vitro and in vivo. (A) BAECs were transfected with CyPA siRNA or scrambled siRNA for 48 h and 
then treated with 10 ng/ml TNF + 10 µg/ml CHX for 6 h. Apoptotic cells were determined by their hypochromic, subdiploid staining profiles (sub-G1 popula-
tion). The data represent the mean ± SD of triplicate samples repeated in three separate experiments. *, P < 0.01 versus scrambled siRNA. (B) Dot-plot dia-
grams of FITC-conjugated annexin V– and PI-stained cells after treatment with TNF + CHX for 3 h. Results are representative of two separate experiments 
that gave similar results. (C) Western blot analyses of cleaved caspase-3 in BAECs treated with TNF + CHX for 6 h. Data represent the mean ± SD of three 
separate experiments. *, P < 0.01 versus scrambled siRNA. (D) Whole-mount en face dual immunofluorescence staining of Apoe/ and Apoe/Ppia/ mice 
aortas after 4 wk of a high-cholesterol diet. Note that these images were obtained from the inner curvature of the aortic arch, which is a region of disturbed 
flow. PECAM-1 staining shows polygonal ECs that are not aligned with flow. TUNEL staining shows increased fluorescence in Apoe/ mice. Bars, 10 µm.  
(E) Quantitative data show that Apoe/Ppia/ mice aortas have a significant decrease in apoptotic cells in the lesion area. The data are expressed as the 
percentage of TUNEL-positive cells per field (four fields per three mice each group). *, P < 0.01 compared with Apoe/ mice. Results are the mean ± SD and 
show pooled data from two experiments.JEM VOL. 208, January 17, 2011 
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digital camera (SPOT Insight 2; Diagnostic Instruments, Inc.). Vessel areas 
and densitometric analysis were measured with Image-Pro Plus software.
En face analysis. Immunofluorescence staining of mouse aortic ECs was 
performed as described previously (Won et al., 2007). Aortas were perfused 
with PBS followed by 2% paraformaldehyde for 10 min. After fixation, the 
aortas were cut in small segments and incubated in blocking buffer contain-
ing 2% BSA. Primary antibody incubations were performed overnight at 
4°C. The primary antibodies used were VCAM-1 (1:200; Santa Cruz Bio-
technology, Inc.), eNOS (1:100; BD), and PECAM-1 (1:200; BD). After 
washing the aortic segments three times, secondary antibodies were added 
and incubated for 1 h. Negative controls included addition of nonimmune 
goat or rabbit IgG. After washing, aortic specimens were opened, placed on 
a glass slide with the luminal side up, and then mounted for confocal micros-
copy (FLUOVIEW; Olympus).
Ex vivo LDL tissue uptake. Apoe/ and Apoe/Ppia/ mice were 
anesthetized and euthanized. Aortas were dissected, cut in small fragments, 
and incubated in 50 µg/ml DiI-LDL. After 2 h, aortas were washed with 
PBS and fixed using 4% paraformaldehyde. Then, aortic segments were 
opened and stained with SYTOX green nucleic acid stain (dilution 1:10,000; 
Invitrogen). After washing, the aortic specimens were prepared for en face 
analysis by confocal microscopy (FLUOVIEW). Analysis of different images 
was performed using Image-Pro Plus software. The results are expressed in 
terms of fluorescence-positive areas for each animal (n = 3 each group,   
4 fields each animal). Human LDL was isolated by ultracentrifugation (1.019 
g/ml < d < 1.063 g/ml) and dialyzed against 0.15 M NaCl/1 mM EDTA 
overnight at 4°C using a 50,000 MWCO dialysis membrane. The LDL   
(250 µg) was directly iodinated using iodobeads (Thermo Fisher Scientific) 
as described by the manufacturer, and unincorporated 125I was removed by 
two rounds of gel filtration on PD10 columns (GE Healthcare) using PBS, 
pH 7.0, as elution buffer. The 125I-labeled LDL was adjusted to a specific   
activity of 500 dpm/ng by addition of unlabeled LDL and then filter steril-
ized using 0.2 µm Acrodisk syringe filter (Pall Life Sciences). More than 98% 
of the radioactivity in the [125I]LDL preparation was precipitable with tri-
chloroacetic acid. For [125I]LDL uptake experiments, aortas (n = 4 each 
group) were incubated with 10 µg/ml [125I]LDL in serum-free medium.   
After a 3-h incubation at 37°C, aortas were washed three times with 2 ml 
PBS and assayed for cell-associated label and protein content (Podrez et al., 
1999). Measurement of radioactivity was performed in a gamma counter 
(Wallac 1470 Automatic Gamma Counter; EG&G Wallac).
Western blot analysis. Aortic tissue samples were frozen with liquid nitro-
gen, crushed, and lysed in cell lysis buffer (Cell Signaling Technology) with 
protease  inhibitor  cocktail  (Sigma-Aldrich).  HUVECs  and  BAECs  were 
washed twice with PBS and harvested on ice in radioimmunoprecipitation 
assay lysis buffer (50 mmol/l Hepes, 10 mmol/l EDTA, 150 mmol/l NaCl, 
1% NP-40, 0.5% Na deoxycholate, and 0.1% SDS, pH 7.4) supplemented 
with the protease inhibitor cocktail. Total cell lysates were loaded on SDS-
PAGE  and  electrotransferred  into  nitrocellulose  membrane  followed  by 
blocking 1 h at room temperature in 5% nonfat dry milk in PBS/0.1% 
Tween 20. After being washed three times with PBS/0.1% Tween 20, the 
blots were incubated overnight at 4°C with the appropriate primary anti-
body. The primary antibodies used were CyPA (1:5,000 dilution; Enzo Life 
Sciences, Inc.), LOX-1 (1:1,000 dilution; Abcam), SR-BI (1:1,000 dilution; 
Abcam), CD36 (1:1,000 dilution; Santa Cruz Biotechnology, Inc.), VCAM-1 
(1:2,000 dilution; Santa Cruz Biotechnology, Inc.), actin (1:5,000 dilution; 
Santa Cruz Biotechnology, Inc.), eNOS (1:1,000 dilution; BD), -tubulin 
(1:5,000 dilution; Sigma-Aldrich), Flag (1:2,000 dilution; Sigma-Aldrich), 
and caspase-3 (1:1,000 dilution; Cell Signaling Technology). ApoB isoforms 
present in serum were determined by immunoblotting with rabbit anti–rat 
apoB antibodies prepared in our laboratory (Chirieac et al., 2000). The mem-
branes were incubated with peroxidase-conjugated secondary antibodies for 
1 h. Signals were visualized using the enhanced chemiluminescence Western 
blotting detection system (GE Healthcare). Images were acquired with a   
with immunosuppression, several of which can be linked to 
its cardiovascular side effects. Moreover, CsA is not a selec-
tive drug for CyPA. In fact, CyPA, -B, and -C all bind with 
high affinity to CsA in vitro (Bram et al., 1993). Therefore, 
the proatherogenic effect of CsA could be related to the in-
hibition of other cyclophilin isoforms. In addition, CsA could 
promote atherosclerosis by a CyPA-independent mechanism. 
For example, CsA directly binds to LDL and affects LDL 
metabolism at several levels (López-Miranda et al., 1993; 
Vaziri et al., 2000). We believe that the discovery of more 
uniquely selective and specific inhibitors of CyPA will be a 
good therapeutic approach for atherosclerosis.
MATERIALS AND METHODS
Animal procedures. All animal experiments were conducted in accor-
dance with experimental protocols that were approved by the University 
Committee on Animal Resources at the University of Rochester. Ppia/ 
mice were purchased from The Jackson Laboratory and were backcrossed to 
C57BL/6J mice for 10 generations. The Apoe/ mice on a C57BL/6J back-
ground  were  obtained  from  The  Jackson  Laboratory.  Double  knockout 
Apoe/Ppia/ mice were generated by crossing Ppia/ mice with Apoe/ 
mice. The F1 generation was backcrossed with Apoe/ mice to fix the 
Apoe/ genotype, and littermates were crossed. All mice were genotyped 
by PCR on tail clip samples, and all experiments were performed with gen-
erations F4–F6 using littermate Apoe/Ppia+/+ as controls. Animals were 
housed under a 12-h light and 12-h dark regimen. Accelerated atherosclero-
sis was induced by feeding the mice for 16 wk with a high-cholesterol diet 
containing 1.25% cholesterol (Research Diets D12108C).
Atherosclerotic lesion analysis. Mice were anesthetized with an intra-
peritoneal injection of 80 mg kg1 ketamine and 5 mg kg1 xylazine. Hearts 
were perfused through the left ventricle with PBS followed by 10% buffered 
formaldehyde. After fixation overnight in 10% formaldehyde, the aortas 
were thoroughly cleaned under a dissecting microscope. All adventitial fat 
and connective tissue was carefully removed. The vessels were then cut open 
longitudinally through the inner curvature and the ventral portions of the 
thoracic and abdominal sections. Aortas were rinsed with 5 ml of 60% iso-
propanol for 5 min. Staining was performed with 5 ml of filtered Oil red   
O solution (Poly Scientific) for 15 min. Vessels were then rinsed with 60% 
isopropanol for 15 min, followed by a final rinse with distilled water. After 
staining, the greater curvature of the aorta was cut to divide the arch in half. 
The vessel was precisely pinned to black wax in PBS to reveal the entire   
luminal surface area. Images were obtained using SPOT version 4.1.1, a 
camera  (SPOT  Insight  4;  Diagnostic  Instruments,  Inc.)  connected  to  a   
microscope (MZ12.5; Leica). Plaques were analyzed in Photoshop 8.0 
(Adobe), and lesion area was quantified using Image-Pro Analyzer 6.2 
(Media Cybernetics).
Histological analysis. Mice were anesthetized and euthanized. For mor-
phological analysis, aortas were perfused with normal saline and fixed with 
10% phosphate-buffered formalin at physiological pressure for 5 min (Satoh 
et al., 2008). The whole aortas and hearts were harvested, fixed for 24 h, and 
embedded in paraffin, and 5-µm cross sections were prepared. Paraffin   
sections were stained with H&E or Masson and Trichrome or used for   
immunostaining. Analyses were performed by using Image-Pro Plus soft-
ware (Media Cybernetics).
Immunohistochemistry. Formaldehyde-fixed paraffin sections were in-
cubated with primary antibody overnight at 4°C. The primary antibodies 
used were Mac3 (clone M3/84; 1:200 dilution; BD) and -smooth muscle 
actin (clone 1A4; 1:1,000 dilution; Sigma-Aldrich). As a negative control, 
species- and isotype-matched IgG were used in place of the primary anti-
body. Slides were viewed with a microscope (BX41; Olympus) and with 64 Cyclophilin A contributes to atherosclerosis | Nigro et al.
with CyPA-WT and vector control for 48 h, HUVECs were washed with 
PBS and loaded with 10 µM 2,7-DCF diacetate (H2DCF-DA; Invitrogen) 
or 5 µM DHE (Invitrogen) for 30 min at 37°C. ROS levels were measured 
using flow cytometry (FACSCanto II). Data from 20,000 events per sample 
were collected, and forward light scatter characteristics were evaluated to 
exclude cell debris from the analysis.
Apoptosis analysis. Apoptotic cells were determined by analyzing their 
subdiploid staining profiles (sub-G1 population). BAECs were cultured in 
the presence of TNF + CHX and then washed in PBS, resuspended (5 × 105 
cells/ml) in PI hypotonic solution (0.1% Na citrate, 0.1% Triton X-100, and 
50 µg/ml PI), and left at 4°C for 30 min in the dark. Data from 20,000 
events per sample were collected by flow cytometry (FACSCanto II). For-
ward light scatter characteristics were used so that cell debris could be ex-
cluded from the analysis. For the estimation of apoptotic cells, cells were 
collected and double labeled with FITC-conjugated annexin V and PI ac-
cording to the manufacturer’s instructions (Trevigen). Green (FITC-conjugated 
annexin V) and red (PI) fluorescence of individual cells were measured by 
flow cytometry (FACSCanto II). Electronic compensation was required to 
exclude overlapping of the two emission spectra. For the detection of apop-
tosis on the whole aortic mount, FITC-labeled dUTP nick end labeling 
(TUNEL) method was applied to the aortic segments by using an In Situ 
Apoptosis Detection kit-POD according to the manufacturer’s instruction 
(Roche). Images were acquired by confocal microscopy (FLUOVIEW).
Statistical  analyses.  Quantitative  results  are  expressed  as  mean  ±  SD. 
Comparisons of parameters among two groups were made by the unpaired 
Student’s t test. Comparisons of parameters among the three groups were 
made by one-way analysis of variance, and comparisons of different parame-
ters between the two genotypes were made by two-way analysis of variance, 
followed by a post hoc analysis using the Bonferroni test. Statistical signifi-
cance  was  evaluated  with  StatView  (StatView  5.0;  SAS  Institute,  Inc.).   
A value of P < 0.05 was considered to be statistically significant.
Online supplemental material. Fig. S1 shows that CyPA deficiency pre-
vents atherosclerosis formation. Fig. S2 shows that CyPA deficiency de-
creases LDL uptake in the lesser curvature of the mouse aorta. Fig. S3 shows 
that CyPA regulates LDL uptake. Fig. S4 shows metabolic parameters in the 
absence of CyPA. Fig. S5 shows that CyPA promotes EC damage and disor-
ganization. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20101174/DC1.
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